Is Bloom Energy The Best Stock to Buy Now?
Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…
Sell
18
CERO Quote, Financials, Valuation and Earnings
Last price:
$0.09
Seasonality move
:
-39.17%
Day range:
$0.09 - $0.10
52-week range:
$0.05 - $205.00
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
188.1K
Avg. volume:
500.5K
1-year change:
-99.93%
Market cap:
$1.8M
Revenue:
--
EPS (TTM):
-$66.73
Earnings Data
Next earnings date for CERO
--
Most recent earnings per share
-$9.10
Missed by $9.10
(Sep 30/2025)
Consensus Estimate
--
(Sep 30/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
CERO Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 12/31/2025 | Q4 | -- | -- | -- | -$0.75 | -- |
| 09/30/2025 | Q3 | -- | -- | -$9.10 | -- | -- |
| 06/30/2025 | Q2 | -- | -- | -$61.71 | -$6.21 | -$55.50 |
| 03/31/2025 | Q1 | -- | -- | -$1.49 | -$119.20 | $117.71 |
| 12/31/2024 | Q4 | -- | -- | $5.56 | -- | -- |
| 09/30/2024 | Q3 | -- | -- | -$0.09 | -- | -- |
| 06/30/2024 | Q2 | -- | -- | -$0.15 | -- | -- |
| 03/31/2024 | Q1 | -- | -- | -$0.16 | -- | -- |
| 12/31/2023 | Q4 | -- | -- | -$4,329.10 | -- | -- |
| 09/30/2023 | Q3 | -- | -- | -$297.58 | -- | -- |
| 06/30/2023 | Q2 | -- | -- | -$461.74 | -- | -- |
| 03/31/2023 | Q1 | -- | -- | -$538.28 | -- | -- |
| 12/31/2022 | Q4 | -- | -- | -$0.04 | -- | -- |
| 09/30/2022 | Q3 | -- | -- | $0.00 | -- | -- |
| 06/30/2022 | Q2 | -- | -- | -$0.00 | -- | -- |
| 03/31/2022 | Q1 | -- | -- | -$0.02 | -- | -- |
| 12/31/2021 | Q4 | -- | -- | -$0.01 | -- | -- |
| 09/30/2021 | Q3 | -- | -- | -- | -- | -- |
| 06/30/2021 | Q2 | -- | -- | -- | -- | -- |
CERo Therapeutics Holdings, Inc. Earnings Questions
-
How Much did CERo Therapeutics Holdings, Inc. Generate in Revenue Last Quarter?
CERo Therapeutics Holdings, Inc. reported -- worth of top line sales in its most recent quarter.
-
Did CERo Therapeutics Holdings, Inc. Beat Earnings Last Quarter?
CERo Therapeutics Holdings, Inc. announced earnings per share of -$9.10 which represents a miss of analyst forecast a -- per share.
-
Is CERo Therapeutics Holdings, Inc. Profitable?
CERo Therapeutics Holdings, Inc. reported -$272.8K that represents -$0.22 per share over the last quarter.
-
What is the Analyst Consensus for CERo Therapeutics Holdings, Inc. EPS Next Year?
CERo Therapeutics Holdings, Inc.'s earnings are forecast to decrease from -$68.74 per share to -$4.29 per share next year representing a decrease of -93.76%.
-
When is CERo Therapeutics Holdings, Inc.'s Earnings Date?
Currently, CERo Therapeutics Holdings, Inc. has not yet stated when its earnings date is, however, based on past estimates it's likely to take place on March 19, 2026.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Berkshire Hathaway Stock Undervalued?
Berkshire Hathaway (NYSE:BRK.A,BRK.B) has undershot the market this year, returning…
Is Oracle Stock Undervalued?
Shares of Oracle (NYSE:ORCL) rocketed higher earlier this year when…
Stock Ideas
Sell
46
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 36x
Buy
67
Is GOOG Stock a Buy?
Market Cap: $3.6T
P/E Ratio: 37x
Alerts
Sell
46
BE alert for Dec 18
Bloom Energy Corp. [BE] is down 12.34% over the past day.
Sell
44
STRL alert for Dec 18
Sterling Infrastructure, Inc. [STRL] is down 11.19% over the past day.
Sell
39
SOXL alert for Dec 18
Direxion Daily Semiconductor Bull 3X Shares [SOXL] is down 10.97% over the past day.
